Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54064
Title: Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.
Authors: 
Keywords: 
Issue Date: Jul-2015
Citation: Ther Adv Vaccines.2015 Jul;(3)4:109-20
Abstract: Herpes zoster (HZ) is primarily a disease of nerve tissue but the acute and longer-term manifestations require multidisciplinary knowledge and involvement in their management. Complications may be dermatological (e.g. secondary bacterial infection), neurological (e.g. long-term pain, segmental paresis, stroke), ophthalmological (e.g. keratitis, iridocyclitis, secondary glaucoma) or visceral (e.g. pneumonia, hepatitis). The age-related increased incidence of HZ and its complications is thought to be a result of the decline in cell-mediated immunity (immunosenescence), higher incidence of comorbidities with age and social-environmental changes. Individuals who are immunocompromised as a result of disease or therapy are also at increased risk, independent of age. HZ and its complications (particularly postherpetic neuralgia) create a significant burden for the patient, carers, healthcare systems and employers. Prevention and treatment of HZ complications remain a therapeutic challenge despite recent advances. This is an overview of the multidisciplinary implications and management of HZ in which the potential contribution of vaccination to reducing the incidence HZ and its complications are also discussed.
PMID: 26478818
URI: https://hdl.handle.net/20.500.12530/54064
ISSN: 2051-0136
Appears in Collections:Centros de Atención Primaria > Artículos

Files in This Item:
File Description SizeFormat 
PMC4591524.pdf1.06 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.